Autoimmune Disorder Drug Delivery Devices Market Overview: 2022-28
Base Year: 2021
Historical Years: 2017-20
Forecast Years: 2022-27
TheAutoimmune Disorder Drug Delivery Devices Market is projected to grow at a CAGR of around 16.89% in terms of revenue during the forecast period, i.e., 2022-27. Increasing environmental triggers such as viruses & bacteria, use of chemical fertilizers, rising exposure to harmful ultraviolet rays, and nutritional deficiencies have resulted in the development of autoimmune diseases such as juvenile dermatomycosis & rheumatoid arthritis, among many others. According to the National Stem Cell Foundation (NCSF), globally, around 4% of the population is affected by one of more than 80 different types of autoimmune diseases.
Markntel Advisor’s Autoimmune Disorder Drug Delivery Devices Market Insights report provides the current and forecast market analysis, individual leading companies’ market shares, challenges, Autoimmune Disorder Drug Delivery Devices Market drivers, barriers, Autoimmune Disorder Drug Delivery Devices Market Trends, and Key Players in Autoimmune Disorder Drug Delivery Devices Market.
Download a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/global-autoimmune-disorder-drug-delivery-devices-market.html
✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
Autoimmune Disorder Drug Delivery Devices Market Dynamics: 2022-27
The selection of T-cells with increased affinity to self-antigens, and latent viruses, which result in the aging of the immune system, are the major factors contributing to an increase in autoimmune disorders in the elderly age population globally. According to the World Health Organization (WHO), the number of people aged over 60 is expected to nearly double from 12% to 22% by 2050.
Furthermore, globally, the aging population & increased immune disorders such as Alzheimer’s Disease, Rheumatoid Arthritis, diabetes, etc., combined with the decrease in gastric pH, which limits drug absorption, are leading to an increase in demand for autoimmune disorder drug delivery devices.
Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/global-autoimmune-disorder-drug-delivery-devices-market.html
Autoimmune Disorder Drug Delivery Devices Market (2022-27): Segmentation Outlook
The market report has segmented the market into the following categories:
- By Indication
- Psoriasis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Inflammatory Bowel Diseases
- Systemic Lupus Erythematosus
- Diabetes Mellitus
- Others (Guillain Barre Syndrome, Grave’s Disease, etc.)
According to report, Of them all, Rheumatoid Arthritis disease is expected to acquire a prominent share in the Global Autoimmune Disorder Drug Delivery Devices market from 2022 to 2027.
- By Product Type
- Prefilled Syringes
- Auto-injectors
- Infusion pumps
- Nebulizers
- Nasal sprays
- Others (Eyedropper, Transdermal patches, etc.)
According to report, Among them, Prefilled Syringes hold a prominent share in the market, owing to the rising demand for convenient & safe-filled syringes over conventional glass vials for parental drug packing.
- By Manufacturing Type
- In-House Manufacturing
- Outsourced Manufacturing
- By End User
- Hospitals
- Diagnostic centres
- Ambulatory surgery centres
- Others (Clinics, Home care settings, etc.)
- By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Note – If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.
Top Companies Operating in the Autoimmune Disorder Drug Delivery Devices Market:
- Amgen Inc.
- AbbVie Inc.
- Bayer AG
- Biogen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Johnson & Johnson Services, Inc.
- The Merck Group
- Novartis International AG
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- UCB Pharma SA.
Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address
About Us –
We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
Contact Us –
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
